Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Carmela Pera

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Neuromuscular Disorders : NMD|December 1, 2022
Long term follow-up of scoliosis progression in type II SMA patientsGiorgia Coratti, Maria Carmela Pera, Adele D'Amico, et al.
European Journal of Pediatrics|January 20, 2022
Body mass index in type 2 spinal muscular atrophy: a longitudinal studyGloria Ferrantini, Giorgia Coratti, Roberta Onesimo, et al.
European Journal of Pediatrics|August 29, 2024
Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort studyMarika Pane, Giulia Stanca, Giorgia Coratti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 28, 2025
Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world dataEmilio Albamonte, Adrea Lizio, Giorgia Coratti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 22, 2023
Early treatment of type II SMA slows rate of progression of scoliosisGiorgia Coratti, Jacopo Lenkowicz, Maria Carmela Pera, et al.
Annals of Clinical and Translational Neurology|February 6, 2021
Type I SMA "new natural history": long-term data in nusinersen-treated patientsMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Annals of Clinical and Translational Neurology|February 15, 2022
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophyMarika Pane, Giorgia Coratti, Maria Carmela Pera, et al.
Muscle & Nerve|January 25, 2019
Revised upper limb module for spinal muscular atrophy: 12 month changesMaria Carmela Pera, Giorgia Coratti, Elena S Mazzone, et al.
Neuromuscular Disorders : NMD|March 29, 2013
Early neurodevelopmental assessment in Duchenne muscular dystrophyMarika Pane, Roberta Scalise, Angela Berardinelli, et al.
Plos One|February 22, 2017
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment toolDanielle Ramsey, Mariacristina Scoto, Anna Mayhew, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Neuromuscular Disorders : NMD|December 1, 2022
Long term follow-up of scoliosis progression in type II SMA patientsGiorgia Coratti, Maria Carmela Pera, Adele D'Amico, et al.
European Journal of Pediatrics|January 20, 2022
Body mass index in type 2 spinal muscular atrophy: a longitudinal studyGloria Ferrantini, Giorgia Coratti, Roberta Onesimo, et al.
European Journal of Pediatrics|August 29, 2024
Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort studyMarika Pane, Giulia Stanca, Giorgia Coratti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 28, 2025
Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world dataEmilio Albamonte, Adrea Lizio, Giorgia Coratti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 22, 2023
Early treatment of type II SMA slows rate of progression of scoliosisGiorgia Coratti, Jacopo Lenkowicz, Maria Carmela Pera, et al.
Annals of Clinical and Translational Neurology|February 6, 2021
Type I SMA "new natural history": long-term data in nusinersen-treated patientsMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Annals of Clinical and Translational Neurology|February 15, 2022
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophyMarika Pane, Giorgia Coratti, Maria Carmela Pera, et al.
Muscle & Nerve|January 25, 2019
Revised upper limb module for spinal muscular atrophy: 12 month changesMaria Carmela Pera, Giorgia Coratti, Elena S Mazzone, et al.
Neuromuscular Disorders : NMD|March 29, 2013
Early neurodevelopmental assessment in Duchenne muscular dystrophyMarika Pane, Roberta Scalise, Angela Berardinelli, et al.
Plos One|February 22, 2017
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment toolDanielle Ramsey, Mariacristina Scoto, Anna Mayhew, et al.
Pageof 9